Carlos Bonilla
Corporate Officer/Principal bei Carlos J. Bonilla & Associates PL
Vermögen: 1 Mio $ am 31.05.2024
Profil
Carlos J.
Bonilla is currently the Principal of Mr. Bonilla & Associates PL.
Previously, he worked as a Director at XenaCare Holdings, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LA ROSA HOLDINGS CORP.
6,82% | 16.04.2024 | 1 010 840 ( 6,82% ) | 1 Mio $ | 31.05.2024 |
Aktive Positionen von Carlos Bonilla
| Unternehmen | Position | Beginn |
|---|---|---|
| Carlos J. Bonilla & Associates PL | Corporate Officer/Principal | 12.05.2011 |
Ehemalige bekannte Positionen von Carlos Bonilla
| Unternehmen | Position | Ende |
|---|---|---|
XenaCare Holdings, Inc.
 XenaCare Holdings, Inc. Pharmaceuticals: OtherHealth Technology XenaCare Holdings, Inc. engages in the formulation, marketing and distribution of nutrition supplement products. It offers Cobroxin for pain medication, XenaCor and XenaTri for cardiovascular health, XenaZyme Plus supports digestion and SunPill for skin protection against ultraviolet rays. The company was founded by Alan P. Xenakis in June 2005 and is headquartered in Tampa, FL. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
XenaCare Holdings, Inc.
XenaCare Holdings, Inc. Pharmaceuticals: OtherHealth Technology XenaCare Holdings, Inc. engages in the formulation, marketing and distribution of nutrition supplement products. It offers Cobroxin for pain medication, XenaCor and XenaTri for cardiovascular health, XenaZyme Plus supports digestion and SunPill for skin protection against ultraviolet rays. The company was founded by Alan P. Xenakis in June 2005 and is headquartered in Tampa, FL. | Health Technology |
| Carlos J. Bonilla & Associates PL |
